Diabetes dietary recommendations of american dietetic association: Difference between revisions

Jump to navigation Jump to search
m (Bot: Removing from Primary care)
 
(9 intermediate revisions by 4 users not shown)
Line 1: Line 1:
__NOTOC__
{{Diabetes mellitus }}
{{Diabetes mellitus }}
{{CMG}}; '''Associate Editor(s)-In-Chief:''' [[Priyamvada Singh|Priyamvada Singh, M.B.B.S.]] [mailto:psingh@perfuse.org]; {{CZ}}
{{CMG}}; '''Associate Editor(s)-In-Chief:''' [[Priyamvada Singh|Priyamvada Singh, M.B.B.S.]] [mailto:psingh13579@gmail.com]; {{CZ}}


==Overview==
==American Dietetic Association: General Nutrition Recommendations (DO NOT EDIT)<ref name="pmid18358257">{{cite journal| author=Franz MJ, Boucher JL, Green-Pastors J, Powers MA| title=Evidence-based nutrition practice guidelines for diabetes and scope and standards of practice. | journal=J Am Diet Assoc | year= 2008 | volume= 108 | issue= 4 Suppl 1 | pages= S52-8 | pmid=18358257 | doi=10.1016/j.jada.2008.01.021 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18358257 }} </ref> ==
 
{{cquote|
==American Dietetic Association: General Nutrition Recommendations (DO NOT EDIT)<ref name="pmid17613449">{{cite journal| author=Rodbard HW, Blonde L, Braithwaite SS, Brett EM, Cobin RH, Handelsman Y et al.| title=American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus. | journal=Endocr Pract | year= 2007 | volume= 13 Suppl 1 | issue= | pages= 1-68 | pmid=17613449 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17613449 }} </ref> ==


===MNT (medical nutrition therapy) and Number/Length of Initial Series of Encounters===
===MNT (medical nutrition therapy) and Number/Length of Initial Series of Encounters===
Line 18: Line 18:
'''Strong, Imperative'''
'''Strong, Imperative'''


Recommendations Strength Rationale
'''Recommendations Strength Rationale'''
* Conclusion statement was Grade I
* '''Conclusion statement was Grade I'''


===DM: Assessment and Diabetes===
===DM: Assessment and Diabetes===
Line 29: Line 29:
'''Strong, Imperative'''
'''Strong, Imperative'''


Recommendations Strength Rationale
'''Recommendations Strength Rationale'''
* Conclusion statement was Grade I
* '''Conclusion statement was Grade I'''


===DM: Assessment of Glycemic Control===
===DM: Assessment of Glycemic Control===
Line 38: Line 38:
'''Strong, Imperative'''
'''Strong, Imperative'''


Recommendation Strength Rationale
'''Recommendation Strength Rationale'''
* Conclusion statement was Grade I
* '''Conclusion statement was Grade I'''


===DM: Assess Relative Importance of Weight Management===
===DM: Assess Relative Importance of Weight Management===
Line 45: Line 45:
The RD should assess the relative importance of weight management for persons with diabetes who are overweight or obese. While modest weight loss has been shown to improve insulin resistance in overweight and obese insulin-resistant individuals, research on sustained weight loss interventions lasting 1 year or longer reported inconsistent effects on A1C.
The RD should assess the relative importance of weight management for persons with diabetes who are overweight or obese. While modest weight loss has been shown to improve insulin resistance in overweight and obese insulin-resistant individuals, research on sustained weight loss interventions lasting 1 year or longer reported inconsistent effects on A1C.


Strong, Conditional
'''Strong, Conditional'''


Recommendation Strength Rationale
'''Recommendation Strength Rationale'''
* Conclusion statement was Grade II
* '''Conclusion statement was Grade II'''


===DM: Intervention Options===
===DM: Intervention Options===
Line 56: Line 56:
'''Strong, Imperative'''
'''Strong, Imperative'''


Recommendation Strength Rationale
'''Recommendation Strength Rationale'''
* Conclusion statement was Grade I
* '''Conclusion statement was Grade I'''


===DM: Macronutrients===
===DM: Macronutrients===
Line 64: Line 64:
The RD should encourage consumption of macronutrients based on the Dietary Reference Intakes (DRI) for healthy adults. Research does not support any ideal percentage of energy from macronutrients for persons with diabetes.
The RD should encourage consumption of macronutrients based on the Dietary Reference Intakes (DRI) for healthy adults. Research does not support any ideal percentage of energy from macronutrients for persons with diabetes.


Strong, Imperative
'''Strong, Imperative'''


Recommendation Strength Rationale
'''Recommendation Strength Rationale'''
* Conclusion statement for Carbohydrate was Grade I
* '''Conclusion statement for Carbohydrate was Grade I'''
* Conclusion statement for Protein was Grade II
* '''Conclusion statement for Protein was Grade II'''


'''DM: Carbohydrate'''
'''DM: Carbohydrate'''
Line 82: Line 82:
'''Strong, Conditional'''
'''Strong, Conditional'''


Recommendation Strength Rational  
'''Recommendation Strength Rational'''
* Conclusion statement was Grade I
* '''Conclusion statement was Grade I'''


===DM: Sucrose and Diabetes===
===DM: Sucrose and Diabetes===
Line 91: Line 91:
'''Strong, Conditional'''
'''Strong, Conditional'''


Recommendation Strength Rationale
'''Recommendation Strength Rationale'''
* Conclusion statement was Grade I
* '''Conclusion statement was Grade I'''


===DM: Non-nutritive Sweeteners and Diabetes===
===DM: Non-nutritive Sweeteners and Diabetes===
Line 98: Line 98:
If persons with diabetes choose to consume products containing U.S. FDA-approved non-nutritive sweeteners, at levels that do not exceed the acceptable daily intakes (ADIs), the RD should advise that some of these products may contain energy and carbohydrate from other sources that needs to be accounted for. Research on non-nutritive sweeteners reports no effect on changes in glycemic response.
If persons with diabetes choose to consume products containing U.S. FDA-approved non-nutritive sweeteners, at levels that do not exceed the acceptable daily intakes (ADIs), the RD should advise that some of these products may contain energy and carbohydrate from other sources that needs to be accounted for. Research on non-nutritive sweeteners reports no effect on changes in glycemic response.


Fair, Conditional
'''Fair, Conditional'''


Recommendation Strength Rationale
'''Recommendation Strength Rationale'''
* Conclusion statements were Grade III
* '''Conclusion statements were Grade III'''


===DM: Glycemic Index and Diabetes===
===DM: Glycemic Index and Diabetes===
Line 107: Line 107:
If the use of glycemic index (GI) is proposed as a method of meal planning, the RD should advise on the conflicting evidence of effectiveness of this strategy. Studies comparing high versus low GI diets report mixed effects on A1C.
If the use of glycemic index (GI) is proposed as a method of meal planning, the RD should advise on the conflicting evidence of effectiveness of this strategy. Studies comparing high versus low GI diets report mixed effects on A1C.


Fair, Conditional
'''Fair, Conditional'''


Recommendation Strength Rationale
'''Recommendation Strength Rationale'''
* Conclusion statement was Grade II
* '''Conclusion statement was Grade II'''


===DM: Fiber and Diabetes===
===DM: Fiber and Diabetes===
Line 116: Line 116:
Recommendations for fiber intake for people with diabetes are similar to the recommendations for the general public (DRI: 14 grams per 1000 kcal). While diets containing 44 to 50 grams of fiber daily are reported to improve glycemia; more usual fiber intakes (up to 24 grams daily) have not shown beneficial effects on glycemia. It is unknown if free-living individuals can daily consume the amount of fiber needed to improve glycemia.
Recommendations for fiber intake for people with diabetes are similar to the recommendations for the general public (DRI: 14 grams per 1000 kcal). While diets containing 44 to 50 grams of fiber daily are reported to improve glycemia; more usual fiber intakes (up to 24 grams daily) have not shown beneficial effects on glycemia. It is unknown if free-living individuals can daily consume the amount of fiber needed to improve glycemia.


Strong, Imperative
'''Strong, Imperative'''


===Fiber Intake and Cholesterol===
===Fiber Intake and Cholesterol===
Line 122: Line 122:
Include foods containing 25 to 30 grams of fiber per day, with special emphasis on soluble fiber sources (7 to 13 grams). Diets high in total and soluble fiber, as part of cardioprotective nutrition therapy, can further reduce total cholesterol by 2% to 3% and LDL cholesterol up to 7%.
Include foods containing 25 to 30 grams of fiber per day, with special emphasis on soluble fiber sources (7 to 13 grams). Diets high in total and soluble fiber, as part of cardioprotective nutrition therapy, can further reduce total cholesterol by 2% to 3% and LDL cholesterol up to 7%.


Strong, Imperative
'''Strong, Imperative'''


Recommendation Strength Rationale
'''Recommendation Strength Rationale'''
* Conclusion statement for Fiber and Diabetes was Grade I
* '''Conclusion statement for Fiber and Diabetes was Grade I'''
* Conclusion statement for Fiber and Coronary Heart Disease (CHD) were Grades I, II, and III
* '''Conclusion statement for Fiber and Coronary Heart Disease (CHD) were Grades I, II, and III'''


===DM: Protein and Diabetes===
===DM: Protein and Diabetes===


Protein Intake and Normal Renal Function
In persons with type 1 or type 2 diabetes with normal [[renal function]], the RD should advise that usual protein intake of approximately '''15% to 20%''' of daily energy intake does not need to be changed. Although protein has an acute effect on insulin secretion, usual protein intake in long-term studies has minimal effects on glucose, lipids, and insulin concentrations.


In persons with type 1 or type 2 diabetes with normal renal function, the RD should advise that usual protein intake of approximately 15% to 20% of daily energy intake does not need to be changed. Although protein has an acute effect on insulin secretion, usual protein intake in long-term studies has minimal effects on glucose, lipids, and insulin concentrations.
'''Fair, Conditional'''


Fair, Conditional
'''Recommendation Strength Rationale'''
 
* '''Conclusion statements were Grade II'''
Recommendation Strength Rationale
* Conclusion statements were Grade II


===DM: Glucose Monitoring===
===DM: Glucose Monitoring===
Blood Glucose Monitoring


For individuals on nutrition therapy alone or nutrition therapy in combination with glucose-lowering medications, SMBG is recommended. Frequency and timing is dependent on diabetes management goals and therapies (i.e., MNT, diabetes medications and physical activity). When SMBG is incorporated into diabetes education programs and the information from SMBG is used to make changes in diabetes management, SMBG is associated with improved glycemic control.
For individuals on nutrition therapy alone or nutrition therapy in combination with glucose-lowering medications, SMBG is recommended. Frequency and timing is dependent on diabetes management goals and therapies (i.e., MNT, diabetes medications and physical activity). When SMBG is incorporated into diabetes education programs and the information from SMBG is used to make changes in diabetes management, SMBG is associated with improved glycemic control.


Fair, Conditional
'''Fair, Conditional'''


Frequency of Blood Glucose Monitoring
'''Frequency of Blood Glucose Monitoring'''


For persons with type 1 or type 2 diabetes on insulin therapy, at least three to eight blood glucose tests per day are recommended to determine the adequacy of the insulin dose(s) and guide adjustments in insulin dose(s), food intake and physical activity. Some insulin regimens require more testing to establish the best integrated therapy (insulin, food, and activity). Once established, some insulin regimens will require less frequent SMBG. Intervention studies that include self-management training and adjustment of insulin doses based on SMBG result in improved glycemic control.
For persons with type 1 or type 2 diabetes on insulin therapy, at least three to eight blood glucose tests per day are recommended to determine the adequacy of the insulin dose(s) and guide adjustments in insulin dose(s), food intake and physical activity. Some insulin regimens require more testing to establish the best integrated therapy (insulin, food, and activity). Once established, some insulin regimens will require less frequent SMBG. Intervention studies that include self-management training and adjustment of insulin doses based on SMBG result in improved glycemic control.


Strong, Conditional
'''Strong, Conditional'''


Possible Need for Continuous Glucose Monitoring or More Frequent SMBG
'''Possible Need for Continuous Glucose Monitoring or More Frequent SMBG'''


Persons experiencing unexplained elevations in A1C or unexplained hypoglycemia and hyperglycemia may benefit from use of CGM or more frequent SMBG. It is essential that persons with diabetes receive education as to how to calibrate CGM and how to interpret CGM results. Studies have proven the accuracy of CGM and most show that using the trend/pattern data from CGM can result in less glucose variability and improved glucose control.
Persons experiencing unexplained elevations in A1C or unexplained hypoglycemia and hyperglycemia may benefit from use of CGM or more frequent SMBG. It is essential that persons with diabetes receive education as to how to calibrate CGM and how to interpret CGM results. Studies have proven the accuracy of CGM and most show that using the trend/pattern data from CGM can result in less glucose variability and improved glucose control.


Fair, Conditional
'''Fair, Conditional'''


Recommendation Strength Rationale
'''Recommendation Strength Rationale'''
* Conclusion statements were Grades I and II
* '''Conclusion statements were Grades I and II'''


===DM: Coordination of Care and Diabetes===
===DM: Coordination of Care and Diabetes===
Coordination of Care


The RD should implement MNT and coordinate care with an interdisciplinary team. An interdisciplinary team approach is necessary to integrate MNT for patients with diabetes into overall management.
The RD should implement MNT and coordinate care with an interdisciplinary team. An interdisciplinary team approach is necessary to integrate MNT for patients with diabetes into overall management.


Consensus, Imperative
'''Consensus, Imperative'''


Recommendation Strength Rationale
'''Recommendation Strength Rationale'''
* Conclusion statement was Grade I
* '''Conclusion statement was Grade I'''


DM: Monitor & Evaluate and Diabetes
===DM: Monitor & Evaluate and Diabetes===


Monitoring and Evaluation
The RD should monitor and evaluate food intake, medication, metabolic control ([[glycemia]], [[lipid]]s, and [[blood pressure]]), [[anthropometric]] measurements and physical activity. Research reports sustained improvements in A1C at 12 months and longer with long-term follow-up encounters with an RD.


The RD should monitor and evaluate food intake, medication, metabolic control (glycemia, lipids, and blood pressure), anthropometric measurements and physical activity. Research reports sustained improvements in A1C at 12 months and longer with long-term follow-up encounters with an RD.
'''Strong, Imperative'''
 
Strong, Imperative


Evaluation of Glycemic Control
'''Evaluation of Glycemic Control'''


The RD should primarily use blood glucose monitoring results in evaluating the achievement of goals and effectiveness of MNT. Glucose monitoring results can be used to determine whether adjustments in foods and meals will be sufficient to achieve blood glucose goals or if medication additions or adjustments need to be combined with MNT.
The RD should primarily use blood [[glucose]] monitoring results in evaluating the achievement of goals and effectiveness of MNT. Glucose monitoring results can be used to determine whether adjustments in foods and meals will be sufficient to achieve blood glucose goals or if medication additions or adjustments need to be combined with MNT.


Consensus, Imperative
'''Consensus, Imperative'''


Recommendation Strength Rationale
'''Recommendation Strength Rationale'''
* Conclusion statement for MNT was Grade I
* '''Conclusion statement for MNT was Grade I'''


}}
}}
Line 195: Line 187:
{{reflist|2}}
{{reflist|2}}


[[Category:Disease state]]
[[Category:Disease]]
[[Category:Medicine]]
[[Category:Medicine]]
[[Category:Endocrinology]]
[[Category:Endocrinology]]
[[Category:Mature chapter]]
[[Category:Mature chapter]]
[[Category:Diabetes]]
[[Category:Diabetes]]
[[Category:Aging-associated diseases]]  
[[Category:Aging-associated diseases]]
[[Category:Medical conditions related to obesity]]
[[Category:Medical conditions related to obesity]]
[[Category:Emergency medicine]]
[[Category:Emergency medicine]]
[[Category:Primary care]]
[[Category:Emergency medicine patient information]]
[[Category:Overview complete]]

Latest revision as of 21:18, 29 July 2020

Diabetes mellitus Main page

Patient Information

Type 1
Type 2

Overview

Classification

Diabetes mellitus type 1
Diabetes mellitus type 2
Gestational diabetes

Differential Diagnosis

Complications

Screening

Diagnosis

Prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Priyamvada Singh, M.B.B.S. [2]; Cafer Zorkun, M.D., Ph.D. [3]

American Dietetic Association: General Nutrition Recommendations (DO NOT EDIT)[1]

MNT (medical nutrition therapy) and Number/Length of Initial Series of Encounters

MNT (medical nutrition therapy) provided by a RD (registered dietitian) is recommended for individuals with type 1 and type 2 diabetes. An initial series of three to four encounters each lasting from 45 to 90 minutes is recommended. This series, beginning at diagnosis of diabetes or at first referral to an RD for MNT for diabetes, should be completed within three to six months. The RD should determine if additional MNT encounters are needed after the initial series based on the nutrition assessment of learning needs and progress towards desired outcomes.

Strong, Imperative

MNT Long-Term Follow-up Encounters

At least one follow-up encounter is recommended annually to reinforce lifestyle changes and to evaluate and monitor outcomes that impact the need for changes in MNT or medication. The RD should determine if additional MNT encounters are needed.

Strong, Imperative

Recommendations Strength Rationale

  • Conclusion statement was Grade I

DM: Assessment and Diabetes

Nutrition Assessment

The RD should assess food intake (focusing on carbohydrate), medication, metabolic control (glycemia, lipids, and blood pressure), anthropometric measurements and physical activity to serve as the basis for implementation of the nutrition prescription, goals and intervention. Individuals who have diabetes should receive MNT tailored by the RD.

Strong, Imperative

Recommendations Strength Rationale

  • Conclusion statement was Grade I

DM: Assessment of Glycemic Control

The RD should assess glycemic control and focus MNT to achieve and maintain blood glucose levels in the target range (target glucose levels noted in the American Diabetes Association Standards of Medical Care in Diabetes).

Strong, Imperative

Recommendation Strength Rationale

  • Conclusion statement was Grade I

DM: Assess Relative Importance of Weight Management

The RD should assess the relative importance of weight management for persons with diabetes who are overweight or obese. While modest weight loss has been shown to improve insulin resistance in overweight and obese insulin-resistant individuals, research on sustained weight loss interventions lasting 1 year or longer reported inconsistent effects on A1C.

Strong, Conditional

Recommendation Strength Rationale

  • Conclusion statement was Grade II

DM: Intervention Options

The RD should implement MNT selecting from a variety of interventions (reduced energy and fat intake, carbohydrate counting, simplified meal plans, healthy food choices, individualized meal planning strategies, exchange lists, insulin-to-carbohydrate ratios, physical activity and behavioral strategies). Nutrition education and counseling should be sensitive to the personal needs, willingness to change, and ability to make changes of the individual with diabetes.

Strong, Imperative

Recommendation Strength Rationale

  • Conclusion statement was Grade I

DM: Macronutrients

The RD should encourage consumption of macronutrients based on the Dietary Reference Intakes (DRI) for healthy adults. Research does not support any ideal percentage of energy from macronutrients for persons with diabetes.

Strong, Imperative

Recommendation Strength Rationale

  • Conclusion statement for Carbohydrate was Grade I
  • Conclusion statement for Protein was Grade II

DM: Carbohydrate

In persons on either MNT alone, glucose-lowering medications or fixed insulin doses, meal and snack carbohydrate intake should be kept consistent on a day-to-day basis. Consistency in carbohydrate intake results in improved glycemic control.

Strong, Conditional

Carbohydrate Intake and Insulin Dose Adjustment

In persons with type 1 or type 2 diabetes who adjust their mealtime insulin doses or who are on insulin pump therapy, insulin doses should be adjusted to match carbohydrate intake (insulin-to-carbohydrate ratio). This can be accomplished by comprehensive nutrition education and counseling on interpretation of blood glucose patterns, nutrition-related medication management and collaboration with the healthcare team. Adjusting insulin dose based on planned carbohydrate intake improves glycemic control and quality of life without any adverse effects.

Strong, Conditional

Recommendation Strength Rational

  • Conclusion statement was Grade I

DM: Sucrose and Diabetes

If persons with diabetes choose to eat foods containing sucrose, the sucrose-containing foods should be substituted for other carbohydrate foods. Sucrose intakes of 10 to 35 percent of total energy intake do not have a negative effect on glycemic or lipid responses when substituted for isocaloric amounts of starch.

Strong, Conditional

Recommendation Strength Rationale

  • Conclusion statement was Grade I

DM: Non-nutritive Sweeteners and Diabetes

If persons with diabetes choose to consume products containing U.S. FDA-approved non-nutritive sweeteners, at levels that do not exceed the acceptable daily intakes (ADIs), the RD should advise that some of these products may contain energy and carbohydrate from other sources that needs to be accounted for. Research on non-nutritive sweeteners reports no effect on changes in glycemic response.

Fair, Conditional

Recommendation Strength Rationale

  • Conclusion statements were Grade III

DM: Glycemic Index and Diabetes

If the use of glycemic index (GI) is proposed as a method of meal planning, the RD should advise on the conflicting evidence of effectiveness of this strategy. Studies comparing high versus low GI diets report mixed effects on A1C.

Fair, Conditional

Recommendation Strength Rationale

  • Conclusion statement was Grade II

DM: Fiber and Diabetes

Recommendations for fiber intake for people with diabetes are similar to the recommendations for the general public (DRI: 14 grams per 1000 kcal). While diets containing 44 to 50 grams of fiber daily are reported to improve glycemia; more usual fiber intakes (up to 24 grams daily) have not shown beneficial effects on glycemia. It is unknown if free-living individuals can daily consume the amount of fiber needed to improve glycemia.

Strong, Imperative

Fiber Intake and Cholesterol

Include foods containing 25 to 30 grams of fiber per day, with special emphasis on soluble fiber sources (7 to 13 grams). Diets high in total and soluble fiber, as part of cardioprotective nutrition therapy, can further reduce total cholesterol by 2% to 3% and LDL cholesterol up to 7%.

Strong, Imperative

Recommendation Strength Rationale

  • Conclusion statement for Fiber and Diabetes was Grade I
  • Conclusion statement for Fiber and Coronary Heart Disease (CHD) were Grades I, II, and III

DM: Protein and Diabetes

In persons with type 1 or type 2 diabetes with normal renal function, the RD should advise that usual protein intake of approximately 15% to 20% of daily energy intake does not need to be changed. Although protein has an acute effect on insulin secretion, usual protein intake in long-term studies has minimal effects on glucose, lipids, and insulin concentrations.

Fair, Conditional

Recommendation Strength Rationale

  • Conclusion statements were Grade II

DM: Glucose Monitoring

For individuals on nutrition therapy alone or nutrition therapy in combination with glucose-lowering medications, SMBG is recommended. Frequency and timing is dependent on diabetes management goals and therapies (i.e., MNT, diabetes medications and physical activity). When SMBG is incorporated into diabetes education programs and the information from SMBG is used to make changes in diabetes management, SMBG is associated with improved glycemic control.

Fair, Conditional

Frequency of Blood Glucose Monitoring

For persons with type 1 or type 2 diabetes on insulin therapy, at least three to eight blood glucose tests per day are recommended to determine the adequacy of the insulin dose(s) and guide adjustments in insulin dose(s), food intake and physical activity. Some insulin regimens require more testing to establish the best integrated therapy (insulin, food, and activity). Once established, some insulin regimens will require less frequent SMBG. Intervention studies that include self-management training and adjustment of insulin doses based on SMBG result in improved glycemic control.

Strong, Conditional

Possible Need for Continuous Glucose Monitoring or More Frequent SMBG

Persons experiencing unexplained elevations in A1C or unexplained hypoglycemia and hyperglycemia may benefit from use of CGM or more frequent SMBG. It is essential that persons with diabetes receive education as to how to calibrate CGM and how to interpret CGM results. Studies have proven the accuracy of CGM and most show that using the trend/pattern data from CGM can result in less glucose variability and improved glucose control.

Fair, Conditional

Recommendation Strength Rationale

  • Conclusion statements were Grades I and II

DM: Coordination of Care and Diabetes

The RD should implement MNT and coordinate care with an interdisciplinary team. An interdisciplinary team approach is necessary to integrate MNT for patients with diabetes into overall management.

Consensus, Imperative

Recommendation Strength Rationale

  • Conclusion statement was Grade I

DM: Monitor & Evaluate and Diabetes

The RD should monitor and evaluate food intake, medication, metabolic control (glycemia, lipids, and blood pressure), anthropometric measurements and physical activity. Research reports sustained improvements in A1C at 12 months and longer with long-term follow-up encounters with an RD.

Strong, Imperative

Evaluation of Glycemic Control

The RD should primarily use blood glucose monitoring results in evaluating the achievement of goals and effectiveness of MNT. Glucose monitoring results can be used to determine whether adjustments in foods and meals will be sufficient to achieve blood glucose goals or if medication additions or adjustments need to be combined with MNT.

Consensus, Imperative

Recommendation Strength Rationale

  • Conclusion statement for MNT was Grade I


References

  1. Franz MJ, Boucher JL, Green-Pastors J, Powers MA (2008). "Evidence-based nutrition practice guidelines for diabetes and scope and standards of practice". J Am Diet Assoc. 108 (4 Suppl 1): S52–8. doi:10.1016/j.jada.2008.01.021. PMID 18358257.